Kristina Pigsborg,Anastasia Z Kalea,Stefano De Dominicis et al.
Kristina Pigsborg et al.
Purpose of review: There is a large variability between individuals in the weight loss response to any given diet treatment, which fuels interest into personalized or precision nutrition. Although most efforts are directe...
Sabotage, Collusion, and Being a Feeder: Towards a New Model of Negative Social Support and Its Impact on Weight Management [0.03%]
恶意支持、串通及充当替罪羊：一种新的消极社会支持模型及其对体重管理的影响
Jane Ogden,Sophia Quirke-McFarlane
Jane Ogden
Purpose of review: Whilst research indicates the positive impact of social support across a number of health domains, including weight management, not all social support is beneficial. ...
Matyas Fehervari,Michael G Fadel,Marcus Reddy et al.
Matyas Fehervari et al.
Purpose of review: To evaluate the current state of bariatric medicolegal activity and explore the reasons of litigation in bariatric surgery. The underlying legal principles in bariatric medicolegal cases and most freque...
Effects of Nutrition and Exercise Interventions on Persons with Sarcopenic Obesity: An Umbrella Review of Meta-Analyses of Randomised Controlled Trials [0.03%]
营养和运动干预对 sarcopenic肥胖患者的影响：随机对照试验的 meta分析伞式回顾
Lea Reiter,Silvia Bauer,Mariella Traxler et al.
Lea Reiter et al.
Background: Sarcopenic obesity (SO) is an increasing phenomenon and has been linked to several negative health consequences. The aim of this umbrella review is the assessment of effectiveness and certainty of evidence of ...
Ioannis G Lempesis,Dimitrios Varrias,Marios Sagris et al.
Ioannis G Lempesis et al.
Purpose of review: Obesity is a significant public health problem and a major risk factor for the development and progression of atherosclerosis and its cardiovascular manifestations. Lower extremity peripheral artery dis...
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications [0.03%]
减重之外：获益差异或可指导减肥药物选择
Valeria Guglielmi,Silvia Bettini,Paolo Sbraccia et al.
Valeria Guglielmi et al.
Purpose of review: To highlight the added benefits of approved and upcoming, centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and cardiovascular effects but also on their less explored ...
Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease [0.03%]
肥胖、2型糖尿病和非酒精性脂肪肝病中的骨保护素/核因子κB受体活化剂配基/核因子κB受体活化剂轴
Ilias D Vachliotis,Stergios A Polyzos
Ilias D Vachliotis
Purpose of review: To summarize evidence on the potential involvement of the osteoprotegerin (OPG)/receptor activator of nuclear factor-kappa B (NF-κΒ) ligand (RANKL)/receptor activator of NF-κΒ (RANK) axis in the pat...
Short-Chain Fatty Acids-A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal Line [0.03%]
微生物组产物短链脂肪酸及其在微生物组-宿主哺乳动物双向通信中的作用
Oliwia Lange,Monika Proczko-Stepaniak,Adriana Mika
Oliwia Lange
Purpose of review: The review aims to describe short-chain fatty acids (SCFAs) as metabolites of bacteria, their complex influence on whole-body metabolism, and alterations in the SCFA profile in obesity and after bariatr...
Obesity in Sexual and Gender Minority Populations: Prevalence and Correlates [0.03%]
肥胖在性与性别少数人群中的流行率及其影响因素研究
Serena D Stevens
Serena D Stevens
Purpose of review: The purpose of this review is to explore the prevalence and correlates of obesity among members of sexual and gender minority (SGM) populations. ...
GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use [0.03%]
肥胖炎症性肠病患者的GLP-1受体激动剂：从分子机制到临床应用的考量及安全有效使用的实用建议
Konstantinos Arvanitakis,Theocharis Koufakis,Djordje Popovic et al.
Konstantinos Arvanitakis et al.
Purpose of review: To discuss current literature and provide practical recommendations for the safe and effective use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in people with inflammatory bowel disease (IBD)...